Skip to main content

U.K. trial sparks interest in dexamethasone’s potential as a treatment for severely ill COVID-19 patients

A snapshot of data from a clinical trial in the U.K. testing a commonly prescribed steroid as a treatment for some severely ill COVID-19 patients reduced deaths among those patients, a finding that sent U.S. stocks soaring on Tuesday morning.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.